Ken Fisher’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.4M | Sell |
736,747
-38,232
| -5% | -$684K | ﹤0.01% | 374 |
|
|
2025
Q4 | $12.4M | Sell |
774,979
-49,600
| -6% | -$738K | ﹤0.01% | 381 |
|
|
2025
Q3 | $10.2M | Sell |
824,579
-43,147
| -5% | -$506K | ﹤0.01% | 405 |
|
|
2025
Q2 | $10M | Sell |
867,726
-143,838
| -14% | -$1.71M | ﹤0.01% | 411 |
|
|
2025
Q1 | $15.2M | Buy |
1,011,564
+70,295
| +7% | +$1.18M | 0.01% | 356 |
|
|
2024
Q4 | $16.3M | Sell |
941,269
-48,998
| -5% | -$945K | 0.01% | 370 |
|
|
2024
Q3 | $18.3M | Buy |
990,267
+161,278
| +19% | +$3.24M | 0.01% | 350 |
|
|
2024
Q2 | $16.8M | Buy |
828,989
+4,844
| +0.6% | +$85.7K | 0.01% | 355 |
|
|
2024
Q1 | $14.1M | Buy |
824,145
+69,738
| +9% | +$1.1M | 0.01% | 373 |
|
|
2023
Q4 | $13.3M | Buy |
754,407
+134,227
| +22% | +$2.7M | 0.01% | 377 |
|
|
2023
Q3 | $14.9M | Buy |
620,180
+430,756
| +227% | +$10.6M | 0.01% | 384 |
|
|
2023
Q2 | $4.4M | Hold |
189,424
| – | – | ﹤0.01% | 561 |
|
|
2023
Q1 | $4.18M | Sell |
189,424
-687
| -0.4% | -$16.1K | ﹤0.01% | 565 |
|
|
2022
Q4 | $3.85M | Buy |
190,111
+116
| +0.1% | +$2.25K | ﹤0.01% | 559 |
|
|
2022
Q3 | $2.56M | Sell |
189,995
-200
| -0.1% | -$3.37K | ﹤0.01% | 538 |
|
|
2022
Q2 | $3.77M | Sell |
190,195
-673,711
| -78% | -$17.9M | ﹤0.01% | 450 |
|
|
2022
Q1 | $27.3M | Buy |
863,906
+26,827
| +3% | +$752K | 0.02% | 292 |
|
|
2021
Q4 | $18.7M | Buy |
837,079
+240,721
| +40% | +$6.28M | 0.01% | 325 |
|
|
2021
Q3 | $16.5M | Sell |
596,358
-163,674
| -22% | -$4.98M | 0.01% | 329 |
|
|
2021
Q2 | $29.6M | Sell |
760,032
-74,318
| -9% | -$2.66M | 0.02% | 281 |
|
|
2021
Q1 | $24M | Sell |
834,350
-50,904
| -6% | -$1.74M | 0.02% | 293 |
|
|
2020
Q4 | $23.5M | Sell |
885,254
-1,140
| -0.1% | -$23.3K | 0.02% | 293 |
|
|
2020
Q3 | $13.5M | Sell |
886,394
-21,743
| -2% | -$456K | 0.01% | 311 |
|
|
2020
Q2 | $18.5M | Sell |
908,137
-22,694
| -2% | -$407K | 0.02% | 280 |
|
|
2020
Q1 | $9.63M | Sell |
930,831
-77,652
| -8% | -$2.17M | 0.01% | 308 |
|
|
2019
Q4 | $38M | Sell |
1,008,483
-59,694
| -6% | -$2.68M | 0.04% | 214 |
|
|
2019
Q3 | $49.8M | Sell |
1,068,177
-7,633
| -0.7% | -$355K | 0.05% | 197 |
|
|
2019
Q2 | $56.2M | Sell |
1,075,810
-12,613
| -1% | -$740K | 0.06% | 187 |
|
|
2019
Q1 | $75M | Buy |
1,088,423
+319,148
| +41% | +$21.4M | 0.09% | 150 |
|
|
2018
Q4 | $45.9M | Buy |
769,275
+47,867
| +7% | +$4.13M | 0.06% | 189 |
|
|
2018
Q3 | $83.6M | Buy |
721,408
+270,723
| +60% | +$30.5M | 0.1% | 144 |
|
|
2018
Q2 | $56.9M | Buy |
450,685
+12,671
| +3% | +$1.54M | 0.07% | 180 |
|
|
2018
Q1 | $47.4M | Buy |
+438,014
| New | +$48.5M | 0.06% | 203 |
|
Other funds holding CLB
AI
DGI
CAMG
VCM
VPM
Ken Fisher's CLB Position: Q1 2026 in Review
Ken Fisher reduced its Core Laboratories (CLB) stake by 4.9% in Q1 2026, selling an estimated $684K and leaving 736,747 shares worth $12.4M. The position accounts for ﹤0.01% of the portfolio, ranked #374.
Ken Fisher first reported a position in CLB in Q1 2018 and has held it in 33 quarters since. The position peaked at $83.6M in Q3 2018. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.
- Ken Fisher held 736,747 shares of Core Laboratories worth $12.4M as of Q1 2026.
- Ken Fisher sold 38,232 Core Laboratories shares in Q1 2026, an estimated $684K.
- Core Laboratories made up ﹤0.01% of Ken Fisher's portfolio in Q1 2026, its #374 holding.
- Ken Fisher first reported a position in Core Laboratories in Q1 2018 and has held it in 33 quarters since.
- Ken Fisher's Core Laboratories position peaked at $83.6M in Q3 2018.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.
Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.